Twist Bioscience Corp. (TWST)
139.92
+4.45
(+3.28%)
USD |
NASDAQ |
Oct 23, 16:00
138.96
-0.96
(-0.69%)
After-Hours: 20:00
Twist Bioscience Price to Book Value : 19.67 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 19.67 |
| October 22, 2026 | 19.05 |
| October 21, 2026 | 20.97 |
| October 20, 2026 | 20.06 |
| October 19, 2026 | 19.65 |
| October 16, 2026 | 18.67 |
| October 15, 2026 | 20.32 |
| October 14, 2026 | 20.83 |
| October 13, 2026 | 21.28 |
| October 12, 2026 | 21.35 |
| October 09, 2026 | 22.47 |
| October 08, 2026 | 21.38 |
| October 07, 2026 | 21.89 |
| October 06, 2026 | 23.48 |
| October 05, 2026 | 28.82 |
| October 02, 2026 | 26.53 |
| October 01, 2026 | 26.44 |
| September 30, 2026 | 27.17 |
| September 29, 2026 | 26.17 |
| September 28, 2026 | 25.25 |
| September 25, 2026 | 25.71 |
| September 24, 2026 | 25.88 |
| September 23, 2026 | 22.29 |
| September 22, 2026 | 23.14 |
| September 21, 2026 | 23.32 |
| Date | Value |
|---|---|
| September 18, 2026 | 23.48 |
| September 17, 2026 | 21.87 |
| September 16, 2026 | 20.12 |
| September 15, 2026 | 19.42 |
| September 14, 2026 | 18.95 |
| September 11, 2026 | 17.89 |
| September 10, 2026 | 17.84 |
| September 09, 2026 | 17.65 |
| September 08, 2026 | 18.01 |
| September 04, 2026 | 17.54 |
| September 03, 2026 | 18.10 |
| September 02, 2026 | 18.42 |
| September 01, 2026 | 18.57 |
| August 31, 2026 | 19.54 |
| August 28, 2026 | 19.88 |
| August 27, 2026 | 21.53 |
| August 26, 2026 | 21.10 |
| August 25, 2026 | 21.29 |
| August 24, 2026 | 19.80 |
| August 21, 2026 | 20.47 |
| August 20, 2026 | 19.17 |
| August 19, 2026 | 20.02 |
| August 18, 2026 | 16.32 |
| August 17, 2026 | 17.49 |
| August 14, 2026 | 16.67 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Intellia Therapeutics, Inc. | 2.157 |
| Beam Therapeutics, Inc. | 2.327 |
| 10X Genomics, Inc. | 11.29 |
| Prime Medicine, Inc. | 16.66 |
| Moderna, Inc. | 11.81 |
Price to Book Value Related Metrics
| PS Ratio | 19.90 |
| PEG Ratio | -1.183 |
| Price | 139.92 |
| Earnings Yield | -1.59% |
| Market Cap | 8.769B |
| PEGY Ratio | -1.183 |